PTCT
#1240
PTC Therapeutics, Inc. - Common Stock
70.0 9 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.40%
Variación mensual
-4.50%
Variación en los últimos 6 meses
+4.49%
Cambio anual
+41.68%
Cierres anteriores
71.8 1
Open
70.0 9
Mínimo
70.0 9
Máximo
70.0 9
Volumen
88
Financials
- Market Capitalization 5.85 B
- Employee 991
- Founded 1998
- CEO Matthew B. Klein
- Website www.ptcbio.com
- Headquarter Delaware, United States
- FIGI BBG000QT15P7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
9.76
Relación precio/flujo de caja
3.88
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1225 |  BLTE Belite Bio Inc - American Depositary Shares | 151.72 USD | -3.37% | -5.80% | -1.71% | +144.00% | 5.97 B USD | ||
| 1232 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 105.84 USD | -5.11% | -3.85% | +1.61% | +352.50% | 5.92 B USD | ||
| 1248 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 59.99 USD | -3.13% | -1.28% | -4.67% | +47.07% | 5.81 B USD | ||
| 1276 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 280.49 USD | -1.42% | -2.02% | -2.53% | +49.90% | 5.59 B USD |